ACE inhibitors and related drugs known as angiotensin receptor antagonists (ARAs) are among the most frequently prescribed medicines in UK clinical practice, used to treat conditions such as high blood pressure, heart disease and kidney problems. There have been concerns about a link between these drugs and kidney function but for the first time researchers […]
Athena SWAN Awards Ceremony
Dr Eleanor Bolton, Department of Surgery, attended the Athena SWAN Awards Ceremony in London earlier this month to collect the Silver award on behalf of the School. Dr Bolton, who was part of the team responsible for compiling the successful submission, was presented with the award by Professor Dame Julia Higgins, Emeritus Professor of Polymer Science […]
New urine test to identify type 1 diabetes risks
Up to 40 per cent of young people with type 1 diabetes may go on to develop heart and kidney disease. Now, thanks to research funded by the Juvenile Diabetes Research Foundation Ltd (JRDF), Diabetes UK, and the British Heart Foundation (BHF), simple urine tests could identify those at risk. In the first study of […]
Researchers find Genetic mutation that causes obesity
Researchers from the University of Cambridge and Boston Children’s Hospital have discovered a genetic cause of severe obesity which, although rare, raises new questions about weight gain and energy use. To investigate the gene in humans, Dr Joseph Majzoub, Chief of Endocrinology at Boston Children’s Hospital and lead investigator on the study, collaborated with Professor […]
Professor Hugh Markus joins the Clinical School
We are pleased to announce that Professor Hugh Markus will be joining us on 1st August as Professor of Stroke Medicine. He was previously at St George’s University of London where he was head of the Stroke and Dementia Research Centre and an honorary Neurologist at St George’s Hospital. His research interests are primarily in applying […]
New £3m centre for Cambridge heart researchers
Heart researchers from Cambridge University have received £3 million from the British Heart Foundation (BHF) to fund a BHF Centre of Research Excellence for the next five years. Cambridge is just one of six centres in the UK to be awarded Centre of Excellence funding. The Cambridge BHF Centre of Research Excellence will be a […]
MRC Award for Primary Biliary Cirrhosis Research
A £6 million programme, funded by Industry and the MRC, to carry out the largest ever study to develop new treatments and improve existing therapy for patients with a life threatening liver disease, Primary Biliary Cirrhosis (PBC) has been awarded to four centres in the UK – Cambridge, Newcastle, Imperial College and Birmingham. £5 million […]
$11m raised to develop new anticoagulant drug
A new spin-out company from the University of Cambridge and Addenbrooke’s Hospital, XO1 Ltd, has raised $11m to develop an anticoagulant drug with the potential to save millions of lives by preventing heart attacks without causing bleeding, the side effect of all antithrombotic agents such as warfarin. The drug Ichorcumab is a synthetic antibody based […]
- « Previous Page
- 1
- …
- 30
- 31
- 32
